Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Tuberculosis (Edinb). 2014 Apr 1;94(3):271–276. doi: 10.1016/j.tube.2014.03.007

Table 2.

In vitro potency of SB-P8B2 and SB-P3G2 against non-replicating M. tuberculosis grown under low oxygen conditions.

Concentration μg/mL Log10 (CFU+/−SD) Log10 (CFU) Reduction % Viable Reduction
Control 5.35 ± 0.01 na na
a Isoniazid 4 5.15 ± 0.2 0.2 36
45 5.01 ± 0.32 0.34 54
b Metronidazole 4 4.83 ± 0.06 0.52 70
45 3.39 ± 0.11 1.96 99
c SB-P8B2 4 4.96 ± 0.18 0.39 59
45 4.38 ± 0.14 0.97 89
c SB-P3G2 4 4.87 ± 0.21 0.48 72
a

Isoniazid is not effective against non replicating bacteria.

b

Metronidazole is effective against non-replicating bacteria but has no efficacy against actively dividing bacteria.

c

Representative trisubstituted benzimidazoles.